NONLINEAR ESTIMATION OF GROWTH CURVE MODELS FOR GERMINATION DATA ANALYSIS

Logistic, Gompertz, Richards and Weibull growth curves were evaluated for their suitability as mathematical and empirical models to represent cumulative germination. By avoiding the limitations associated with the method of moments and single-value germination indices, the fitted models provided superior description of the time course of germination. The four-parameter Weibull model gave the best fit across a relatively wide range of seed species and germination conditions, and the resulting parameter estimates reflected identifiable aspects of the germination process. The nonlinear estimation of the germination response included a parameter summary, together with their asymptotic standard errors and correlation matrix, along with an approximate band for the expectation function, pairwise plots of the parameter inference region, and profile t plots. Evaluation of the fitted models also included information on lack of fit and residual structure. Empirical results and hypothesis testing were demonstrated with reference to a replicated experiment designed to determine the effects of reduced water potential on germination of onion seeds

Ethnic minorities in Borneo: the Kimaragang people

This article presents an overview of the Kimaragang ethnic group, where the Kimaragang ethnic group is one of the indigenous sub-ethnic groups of Sabah, with typical settlements in Kota Marudu and Pitas. This article discusses the origins of the Kimaragang ethnic group, their earliest habitation, their language, economy, and sociocultural. It is anticipated that the material in this article will assist researchers, educators, institutions, and organisations in continuing to impart the culture of the indigenous peoples of Sabah, both directly and indirectly, through diverse research, publications, and documentation

BOOTSTRAP ESTIMATION AND COMPARISON OF AN INDEX OF PHYLOGENETIC CORRELATION

A common objective of bioinformatic analyses is to assess the similarity of species, given a biological trait or characteristic. Phylogenetic correlation is one means to achieve this objective. Such measures provide a means to evaluate evolutionary models and history as well as having potential application to ecological relationships including host preference selection. Typically, these measurements are based on the deviation of an observed phylogeny from a Brownian evolutionary model. Statistical inference for this difference is assessed through likelihood ratio tests. These tests, in turn, rely on the assumption of a Normal likelihood within the phylogenetic trait. In addition, statistical comparison of estimated phylogenetic correlations between competing phylogenies or traits has not been addressed. In this paper, a bootstrap resampling methodology is proposed for two common phylogenetic correlation metrics, Pagel’s λ and Blomberg’s K. The underlying bootstrap distribution of the estimates will be utilized as a means of computing confidence limits as well as carrying out hypothesis testing. The method will be demonstrated using phylogenetic and metabolomic data related to the host specificity of an insect, Ceutorhynchus cardariae Korotyaev, on a wide range of Brassicaceae species

COMPARING ESTIMATION PROCEDURES FOR DOSE-RESPONSE FUNCTIONS

The dose-response design is often used in agricultural research when it is necessary to measure a biological response at various levels of an experimental factor. This type of problem is common in chemical and pesticide research, however, it can also occur in other disciplines such as plant, animal, soil, and environmental sciences. While the analysis of dose-response data usually involves fitting a regression curve, the primary objective often centers on the estimation of dose related percentiles such as the LD50 or LC50. These measures are useful for comparing the relative efficacy of various treatments, however, the estimation of the specified percentiles is not always straightforward. Traditional methodology has relied on inverted solutions or asymptotic theory for statistical inference. More recently, computer intensive methods have been used to model dose-response relationships and can be more appropriate than traditional methods in some situations. This paper examines both the traditional and modem approaches to estimating doseresponse functions as they apply to binomial data. The techniques will be demonstrated using mortality data collected on black vine weevil eggs exposed to an organic pesticide treatment

Clinical Predictors and Outcomes After Left Ventricular Assist Device Implantation and Tracheostomy

BACKGROUND: Postoperative respiratory failure is a major complication that affects up to 10% of patients who undergo cardiac surgery and has a high in-hospital mortality rate. Few studies have investigated whether patients who require tracheostomy for postoperative respiratory failure after continuous-flow left ventricular assist device (CF-LVAD) implantation have worse survival outcomes than patients who do not. OBJECTIVE: To identify risk factors for respiratory failure necessitating tracheostomy in CF-LVAD recipients and to compare survival outcomes between those who did and did not require tracheostomy. METHODS: Consecutive patients who underwent primary CF-LVAD placement at a single institution between August 1, 2002, and December 31, 2019, were retrospectively reviewed. Propensity score matching accounted for baseline differences between the tracheostomy and nontracheostomy groups. Multivariate logistic regression was used to identify tracheostomy risk factors and 90-day survival; Kaplan-Meier analysis was used to assess midterm survival. RESULTS: During the study period, 664 patients received a CF-LVAD; 106 (16.0%) underwent tracheostomy for respiratory failure. Propensity score matching produced 103 matched tracheostomy-nontracheostomy pairs. Patients who underwent tracheostomy were older (mean [SD] age, 57.9 [12.3] vs 54.6 [13.9] years; P = .02) and more likely to need preoperative mechanical circulatory support (61.3% vs 47.8%; P = .01) and preoperative intubation (27.4% vs 8.8%; P \u3c .001); serum creatinine was higher in the tracheostomy group (mean [SD], 1.7 [1.0] vs 1.4 [0.6] mg/dL; P \u3c .001), correlating with tracheostomy need (odds ratio, 1.76; 95% CI, 1.21-2.56; P = .003). Both before and after propensity matching, 30-day, 60-day, 90-day, and 1-year survival were worse in patients who underwent tracheostomy. Median follow-up was 0.8 years (range, 0.0-11.2 years). Three-year Kaplan-Meier survival was significantly worse for the tracheostomy group before (22.0% vs 61.0%; P \u3c .001) and after (22.4% vs 48.3%; P \u3c .001) matching. CONCLUSION: Given the substantially increased probability of death in patients who develop respiratory failure and need tracheostomy, those at high risk for respiratory failure should be carefully considered for CF-LVAD implantation. Comprehensive management to decrease respiratory failure before and after surgery is critical

Predictors and Impact of Prolonged Vasoplegia After Continuous-Flow Left Ventricular Assist Device Implantation

BACKGROUND: Vasoplegia after cardiac surgery is associated with adverse outcomes. However, the clinical effects of vasoplegia and the significance of its duration after continuous-flow left ventricular assist device (CF-LVAD) implantation are less known. OBJECTIVES: This study aimed to identify predictors of and outcomes from transient vs prolonged vasoplegia after CF-LVAD implantation. METHODS: The study was a retrospective review of consecutive patients who underwent CF-LVAD implantation between January 1, 2005, and December 31, 2017. Vasoplegia was defined as the presence of all of the following: mean arterial pressure ≤65 mm Hg, vasopressor (epinephrine, norepinephrine, vasopressin, or dopamine) use for \u3e6 hours within the first 24 hours postoperatively, cardiac index ≥2.2 L/min/m RESULTS: Of the 600 patients who underwent CF-LVAD implantation during the study period, 182 (30.3%) developed vasoplegia. Mean patient age was similar between the vasoplegia and no-vasoplegia groups. Prolonged vasoplegia (n = 78; 13.0%), compared with transient vasoplegia (n = 104; 17.3%), was associated with greater 30-day mortality (16.7% vs 5.8%; CONCLUSIONS: Compared with vasoplegia overall, prolonged vasoplegia was associated with worse survival after CF-LVAD implantation. Treatment to avoid or minimize progression to prolonged vasoplegia may be warranted

Note on occurrence of \u3ci\u3eMymaromella pala\u3c/i\u3e Huber and Gibson (Hymenoptera: Mymarommatidae) in Montana: a new state record

The parasitic wasp Mymaromella pala Huber and Gibson (Hymenoptera: Mymarommatidae) was collected at 4 sites within a canyon reach of the Kootenai River in Lincoln County, Montana. This minute species has only recently been described, but it appears to have a large distribution throughout the United States and to be associated with upland and riparian forests.La avispa parasitaria Mymaromella pala Huber y Gibson (Hymenoptera: Mymarommatidae) se recolectó en cuatro sitios a lo largo de un cañón del Río Kootenai en Lincoln Co., MT. Hace poco que se describió esta especie diminuta, pero parece tener una distribución extensa en los EE.UU. y estar asociada con bosques altos y ribereños

Toward an international consensus-Integrating lipoprotein apheresis and new lipid-lowering drugs

Background: Despite advances in pharmacotherapy of lipid disorders, many dyslipidemic patients do not attain sufficient lipid lowering to mitigate risk of atherosclerotic cardiovascular disease. Several classes of novel lipid-lowering agents are being evaluated to reduce atherosclerotic cardiovascular disease risk. Lipoprotein apheresis (LA) is effective in acutely lowering the plasma concentrations of atherogenic lipoproteins including low-density lipoprotein cholesterol and lipoprotein(a), and novel lipid-lowering drugs may dampen the lipid rebound effect of LA, with the possibility that LA frequency may be decreased, in some cases even be discontinued. Sources of material: This document builds on current American Society for Apheresis guidelines and, for the first time, makes recommendations from summarized data of the emerging lipid-lowering drug classes (inhibitors of proprotein convertase subtilisin/kexin type 9 or microsomal triglyceride transfer protein, high-density lipoprotein mimetic), including the available evidence on combination therapy with LA with respect to the management of patients with dyslipidemia. Abstract of findings: Recommendations for different indications are given based on the latest evidence. However, except for lomitapide in homozygous familial hypercholesterolemia and alirocumab/evolocumab in heterozygous familial hypercholesterolemia subjects, limited data are available on the effectiveness and safety of combination therapy. More studies on combining LA with novel lipid-lowering drugs are needed. Conclusion: Novel lipid-lowering agents have potential to improve the performance of LA, but more evidence is needed. The Multidisciplinary International Group for Hemapheresis TherapY and Metabolic DIsturbances Contrast scientific society aims to establish an international registry of clinical experience on LA combination therapy to expand the evidence on this treatment in individuals at high cardiovascular disease risk